Exosomes and non-coding RNAs: Exploring their roles in human myocardial dysfunction
Open Access
- 18 January 2025
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 183, 117853
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survivalBasic Research in Cardiology, 2024
- Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale and Design of the HF-REVERT TrialEuropean Journal of Heart Failure, 2024
- A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failureMolecular Biology Reports, 2022
- Heart Failure due to Left Ventricular Systolic Dysfunction2020
- The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion InjuryCardiovascular Drugs and Therapy, 2019
- MiR‐423‐5p inhibition alleviates cardiomyocyte apoptosis and mitochondrial dysfunction caused by hypoxia/reoxygenation through activation of the wnt/β‐catenin signaling pathway via targeting MYBL2Journal of Cellular Physiology, 2019
- A New Era of Cardiac Cell Therapy: Opportunities and ChallengesAdvanced Healthcare Materials, 2018
- Bioengineering of noncoding RNAs for research agents and therapeuticsWIREs RNA, 2016
- Non‐coding RNAs: biological functions and applicationsCell Biochemistry and Function, 2014
- Synthesis of RNA by In Vitro Transcription2010